← Pediatrix Medical Group, Inc. MD
Market Price
$26.61
Market Cap
$2.17B
P/E Ratio
13.71
Revenue (FY 2025)
↓-4.9% YoY
$1.91B
3-Yr CAGR: -1.0%
Net Income
↑266.9% YoY
$165.39M
Net Margin: 8.6%
Free Cash Flow
↑36.9% YoY
$252.63M
FCF Yield: 11.66%
EPS (Diluted)
↑263.0% YoY
$1.94
Basic: $1.97
Return on Equity
Efficiency
19.1%
ROA: 21.7%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (MD)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $3,183.2M | — | $1,033.5M | $324.9M | — | $3.49 | — | $443.8M | — | — |
| FY 2017 | $3,458.3M | +8.6% | $1,000.1M | $320.4M | -1.4% | $3.45 | -1.1% | $511.4M | — | — |
| FY 2018 | $3,647.1M | +5.5% | $989.5M | $268.6M | -16.2% | $2.93 | -15.1% | $289.9M | — | — |
| FY 2019 | $3,513.5M | -3.7% | $892.0M | $-1,497.7M | -657.5% | $-17.94 | -712.3% | $346.6M | — | — |
| FY 2020 | $1,734.0M | -50.6% | $449.3M | $-796.5M | +46.8% | $-9.55 | +46.8% | $204.6M | — | — |
| FY 2021 | $1,911.2M | +10.2% | $513.2M | $131.0M | +116.4% | $1.53 | +116.0% | $76.7M | — | — |
| FY 2022 | $1,972.0M | +3.2% | $467.0M | $66.3M | -49.3% | $0.79 | -48.4% | $166.9M | $137.2M | — |
| FY 2023 | $1,994.6M | +1.1% | $421.6M | $-60.4M | -191.1% | $0.73 | -7.6% | $137.3M | $104.0M | -24.2% |
| FY 2024 | $2,012.9M | +0.9% | $454.3M | $-99.1M | -64.0% | $-1.19 | -263.0% | $206.6M | $184.6M | +77.5% |
| FY 2025 | $1,913.8M | -4.9% | $493.7M | $165.4M | +266.9% | $1.94 | +263.0% | $271.1M | $252.6M | +36.9% |
Valuation
Market Price
$26.61
Market Cap
$2.17B
Enterprise Value
N/A
P/E Ratio
13.71
P/B Ratio
2.52
FCF Yield
11.66%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
25.80%
Operating Margin
10.91%
Net Margin
8.64%
Return on Equity (ROE)
19.10%
Return on Assets (ROA)
21.66%
Asset Turnover
2.51x
Revenue 3-Yr CAGR
-0.99%
Financial Health & Liquidity
Current Ratio
1.66
Cash Ratio
0.82
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$375.24M
Total Debt
N/A
Book Value / Share
$10.54
Cash Flow Efficiency
Operating Cash Flow
$271.09M
Capital Expenditures (CapEx)
$18.46M
Free Cash Flow
$252.63M
OCF / Revenue
14.16%
FCF / Revenue
13.20%
FCF 3-Yr CAGR
22.56%
Per Share Metrics
EPS (Diluted)
$1.94
EPS (Basic)
$1.97
Dividends / Share
N/A
Book Value / Share
$10.54
EPS YoY Growth
263.03%
Balance Sheet (FY 2025)
Total Assets
$763.51M
Total Liabilities
$458.91M
Stockholders' Equity
$865.85M
Current Assets
$763.51M
Current Liabilities
$458.91M